Outcomes of ESKD Patients Hospitalized with COVID-19

Background: Patients with ESKD have a dysregulated immune system and a higher annual mortality rate compared with the general population We aimed to describe the clinical characteristics and compare the outcomes of patients with and without ESKD, among those hospitalized with COVID-19 disease Methods: We reviewed the health records for all patients hospitalized with Covid-19 between March 1, 2020 and April 27, 2020 from 13 hospitals in New York Patients ;7 days was higher in the ESKD group compared to the non-ESKD group, in both the crude analysis and the adjusted analysis (OR 1 62, 95% CI 1 3 - 2 1;adjusted OR 1 6, 95% CI 1 3 - 2 1) The independent predictors for death for non ESKD patients were age, male gender, cancer, CHF, elevated BUN, low albumin and being on a ventilator The independent predictors of death for ESKD patients were age, lymphopenia, low albumin and being on a ventilator Black race was associated with lower risk of death Conclusions: ESKD patients had a higher rate of mortality compared to non-ESKD patients hospitalized with COVID-19 Black race was associated with a lower risk of death among ESKD patients compared to white patients